Exenatide offers glucose benefits in type 1 diabetes

08/16/2013 | MedPage Today (free registration)

Type 1 diabetes patients who took exenatide prior to a mixed meal tolerance test attained a 33% reduction in glucose excursion and delays in gastric emptying, according to a small study in Diabetes Care. However, the drug did not appear to boost insulin secretion rates and did not show metabolic effects when taken before an intravenous glucose tolerance test, researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA